scholarly journals 831MO Geptanolimab in Chinese patients with relapsed or refractory primary mediastinal large B-cell lymphoma: Results from a multicenter, open-label, single-arm phase II trial

2021 ◽  
Vol 32 ◽  
pp. S775-S776
Author(s):  
Y-K. Shi ◽  
J. Cui ◽  
H. Zhou ◽  
X. Zhang ◽  
L.Q. Zou ◽  
...  
Keyword(s):  
B Cell ◽  
Phase Ii ◽  
Phase Ii Trial ◽  
Cell Lymphoma ◽  
B Cell Lymphoma ◽  
Chinese Patients ◽  
Open Label ◽  
Large B Cell Lymphoma ◽  
Large B Cell

scholarly journals Final results of a phase II trial of R-IDEA as salvage therapy in patients with relapsed/refractory diffuse large B-cell lymphoma

2016 ◽  
Vol 27 ◽  
pp. vi321
Author(s):  
E. Kondo ◽  
K. Yamamoto ◽  
T. Masunari ◽  
J. Takizawa ◽  
K. Miura ◽  
...  
Keyword(s):  
B Cell ◽  
Phase Ii ◽  
Salvage Therapy ◽  
Phase Ii Trial ◽  
Cell Lymphoma ◽  
B Cell Lymphoma ◽  
Large B Cell Lymphoma ◽  
Large B Cell

Updated results of a phase II trial of brentuximab vedotin combined with R-CHOP in frontline treatment of patients (pts) with high-intermediate/high-risk diffuse large B-cell lymphoma (DLBCL).

2015 ◽  
Vol 33 (15_suppl) ◽  
pp. 8506-8506 ◽  
Author(s):  
Nancy L. Bartlett ◽  
Charles M. Farber ◽  
Christopher A. Yasenchak ◽  
Stephen Maxted Ansell ◽  
Ranjana H. Advani ◽  
...  
Keyword(s):  
High Risk ◽  
B Cell ◽  
Phase Ii ◽  
Phase Ii Trial ◽  
Cell Lymphoma ◽  
B Cell Lymphoma ◽  
Brentuximab Vedotin ◽  
Large B Cell Lymphoma ◽  
Frontline Treatment ◽  
Large B Cell

scholarly journals A phase II trial of bendamustine in combination with rituximab in older patients with previously untreated diffuse large B-cell lymphoma

2016 ◽  
Vol 175 (2) ◽  
pp. 281-289 ◽  
Author(s):  
Steven I. Park ◽  
Natalie S. Grover ◽  
Oludamilola Olajide ◽  
Adam S. Asch ◽  
James G. Wall ◽  
...  
Keyword(s):  
B Cell ◽  
Phase Ii ◽  
Older Patients ◽  
Phase Ii Trial ◽  
Cell Lymphoma ◽  
B Cell Lymphoma ◽  
Large B Cell Lymphoma ◽  
Large B Cell

A Phase II Trial of Bortezomib and Vorinostat in Mantle Cell Lymphoma and Diffuse Large B-cell Lymphoma

2018 ◽  
Vol 18 (9) ◽  
pp. 569-575.e1 ◽  
Author(s):  
Victor Yazbeck ◽  
Danielle Shafer ◽  
Edward B. Perkins ◽  
Domenico Coppola ◽  
Lubomir Sokol ◽  
...  
Keyword(s):  
B Cell ◽  
Mantle Cell Lymphoma ◽  
Phase Ii ◽  
Phase Ii Trial ◽  
Cell Lymphoma ◽  
B Cell Lymphoma ◽  
Large B Cell Lymphoma ◽  
Mantle Cell ◽  
Large B Cell

scholarly journals A multicentre, phase II trial of ofatumumab monotherapy in relapsed/progressive diffuse large B-cell lymphoma

2013 ◽  
Vol 163 (3) ◽  
pp. 334-342 ◽  
Author(s):  
Bertrand Coiffier ◽  
John Radford ◽  
André Bosly ◽  
Giovanni Martinelli ◽  
Gabriela Barca ◽  
...  
Keyword(s):  
B Cell ◽  
Phase Ii ◽  
Phase Ii Trial ◽  
Cell Lymphoma ◽  
B Cell Lymphoma ◽  
Multicentre Phase ◽  
Large B Cell Lymphoma ◽  
Large B Cell

scholarly journals Idelalisib in relapsed/refractory diffuse large B‐cell lymphoma: results from a Nordic Lymphoma Group phase II trial

2021 ◽  
Author(s):  
Karin Fjordén ◽  
Sara Ekberg ◽  
Nevzeta Kuric ◽  
Karin E. Smedby ◽  
Ingemar Lagerlöf ◽  
...  
Keyword(s):  
B Cell ◽  
Phase Ii ◽  
Phase Ii Trial ◽  
Cell Lymphoma ◽  
B Cell Lymphoma ◽  
Large B Cell Lymphoma ◽  
Large B Cell

scholarly journals PCN325 Health Utility in Relapsed/Refractory Diffuse Large B-Cell Lymphoma (RR-DLBCL) Patients - Results of a Phase II Trial with ORAL Selinexor

2020 ◽  
Vol 23 ◽  
pp. S479-S480
Author(s):  
R.O. Casasnovas ◽  
P. Daniele ◽  
G. Tremblay ◽  
M. Maerevoet ◽  
J. Zijlstra ◽  
...  
Keyword(s):  
B Cell ◽  
Phase Ii ◽  
Phase Ii Trial ◽  
Cell Lymphoma ◽  
B Cell Lymphoma ◽  
Health Utility ◽  
Large B Cell Lymphoma ◽  
Large B Cell
Sign in / Sign up

Export Citation Format

Share Document